8CZG
 
 | | Human BAK in complex with the dF3 peptide | | 分子名称: | Bcl-2 homologous antagonist/killer, dF3 peptide | | 著者 | Aguilar, F, Keating, A.E. | | 登録日 | 2022-05-24 | | 公開日 | 2023-01-11 | | 最終更新日 | 2023-10-25 | | 実験手法 | X-RAY DIFFRACTION (1.99 Å) | | 主引用文献 | Peptides from human BNIP5 and PXT1 and non-native binders of pro-apoptotic BAK can directly activate or inhibit BAK-mediated membrane permeabilization.
Structure, 31, 2023
|
|
8CZH
 | | Human BAK in complex with the dM2 peptide | | 分子名称: | Bcl-2 homologous antagonist/killer, DM2 peptide | | 著者 | Aguilar, F, Keating, A.E. | | 登録日 | 2022-05-24 | | 公開日 | 2023-01-11 | | 最終更新日 | 2024-10-09 | | 実験手法 | X-RAY DIFFRACTION (1.3 Å) | | 主引用文献 | Peptides from human BNIP5 and PXT1 and non-native binders of pro-apoptotic BAK can directly activate or inhibit BAK-mediated membrane permeabilization.
Structure, 31, 2023
|
|
8CZF
 | | Human BAK in complex with the dF2 peptide | | 分子名称: | Bcl-2 homologous antagonist/killer, DF2 peptide | | 著者 | Aguilar, F, Keating, A.E. | | 登録日 | 2022-05-24 | | 公開日 | 2023-01-11 | | 最終更新日 | 2024-10-23 | | 実験手法 | X-RAY DIFFRACTION (1.3 Å) | | 主引用文献 | Peptides from human BNIP5 and PXT1 and non-native binders of pro-apoptotic BAK can directly activate or inhibit BAK-mediated membrane permeabilization.
Structure, 31, 2023
|
|
6C00
 | |
